http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2257284-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate | 1997-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45fea8004992cca437dc36e3f8dcb8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9080123aa6dc9b4ed9a2405931283f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1551cba1d2a0686c7b61bea20dd859 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f3fc710a17f142da0d8b86d4d1f558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62345a69e6293df7a9b0e8afc58042c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db569f54ea6e1ab7a84a28d45f39e4c |
| publicationDate | 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2257284-C |
| titleOfInvention | Remedy for autoimmune diseases |
| abstract | A preventive or therapeutic agent for autoimmune diseases (excluding Type I diabetes) comprising a thiazolidinedione compound, preferably as defined in Formula (I): (see figure I) wherein: R1a and R2a may be the same or different and each represents a hydrogen at om or a C1-C5 alkyl group; R3a represents a hydrogen atom, a C1-C6 aliphatic acyl group, a C6-C8 cycloalkylcarbonyl group, a benzoyl or naphthoyl group which may have a substituent (the substituent is a C1-C4 alkyl, C1-C4 alkoxy or hydroxy group, a halogen atom, or an amino, mono-C1-C4 alkylamino, di-C1-C4 alkylamino or nitro group), a 4- t o 7- membered heterocyclic acyl group containing from 1 to 3 hetero atoms selecte d from the hetero atom group consisting of nitrogen, oxygen and sulfur atoms, a phenylacetyl group, a phenylpropionyl group, a phenylacetyl or phenylpropionyl group substituted with at least one halogen atom, a cinnamoyl group, a C2-C7 alkoxycarbonyl group or a benzyloxycarbonyl group; R4a and R5a may be the same or different and each represents a hydrogen atom, a C1-C5 alkyl group or a C1-C5 alkoxy group, or R4' and R5' taken together represent a C1-C4 alkylenedioxy group; Y a and Z a each represents an oxygen atom; and n' is an integer of 1 to 3; or a pharmacologically acceptable salt thereof. |
| priorityDate | 1996-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 257.